← Back to Search

Tailored Exercise Program for Childhood Cancer Survivors with Limited Mobility

N/A
Recruiting
Led By Kirsten Ness, PhD
Research Sponsored by St. Jude Children's Research Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 18.00 and 39.99 years of age at the time of enrollment
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 20 to 6 months after week 20
Awards & highlights

Study Summary

This trial is testing whether a personalized exercise plan can help childhood cancer survivors who have exercise intolerance become more active.

Who is the study for?
This trial is for childhood cancer survivors aged 18-40 with limited exercise ability due to past treatments. They must understand how to use ZOOM and a heart rate monitor, have internet access, and get clearance from a study doctor. It's not for those in other exercise programs, very active individuals, pregnant women, or those needing urgent medical care.Check my eligibility
What is being tested?
The study tests if a personalized home-based aerobic and strengthening program can improve physical capacity in these survivors. It also looks at the effects on heart, lung function, muscles, nerves, emotional health, social participation, life quality and thinking skills.See study design
What are the potential side effects?
Since this intervention involves an exercise program tailored to each participant's abilities rather than medication or invasive procedures; side effects may include typical exercise-related discomforts such as muscle soreness or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 39 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 20 to 6 months after week 20
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 20 to 6 months after week 20 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise Capacity
Exercise capacity
Secondary outcome measures
Childhood Cancer Survivor Study Neurocognitive Questionnaire - Revised (CCSS-NCQ)
Generalized Anxiety Disorder (GAD-7)
Medical Outcomes Survey Short Form (SF-36)
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Personalized exercise group (INTGroup)Experimental Treatment2 Interventions
Participants in this group have individually tailored exercise program with supervision, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.
Group II: Generalized exercise group, Attention Control (AC Group)Experimental Treatment2 Interventions
Study participants in this group receive generalized exercise recommendations, 20 weeks,clinic 3 times during the course of this study: at baseline (this appointment), at 4 months and 10 months from now for follow-up.

Find a Location

Who is running the clinical trial?

St. Jude Children's Research HospitalLead Sponsor
427 Previous Clinical Trials
5,306,417 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,187 Total Patients Enrolled
Kirsten Ness, PhDPrincipal InvestigatorSt. Jude Children's Research Hospital
1 Previous Clinical Trials
6,000 Total Patients Enrolled

Media Library

Individually tailored exercise program Clinical Trial Eligibility Overview. Trial Name: NCT04714840 — N/A
Childhood Cancer Research Study Groups: Personalized exercise group (INTGroup), Generalized exercise group, Attention Control (AC Group)
Childhood Cancer Clinical Trial 2023: Individually tailored exercise program Highlights & Side Effects. Trial Name: NCT04714840 — N/A
Individually tailored exercise program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04714840 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment process for this research initiative still open?

"Affirmative. According to clinicaltrials.gov, this scientific experiment is actively seeking participants and was initially published on February 8th 2021. It has seen its last revision in April 12th 2022 and requires 160 patients from a single site."

Answered by AI

What are the essential goals of this research endeavor?

"Within a timeline from the initial Baseline to Week 20, this trial seeks to assess and improve exercise capacity. Secondary outcomes such as PROMIS Ability to Participate 8a (SF v2.0), Work Productivity and Activity Impairment Questionnaire (WPAI) and PROMIS Global Health Short Forms will be measured using 5-point Likert scales or expressed in impairment percentages, with higher scores representing worse outcomes."

Answered by AI

Is there a way for me to partake in this clinical exploration?

"For qualification into this experiment, participants must have impaired mobility and be within the range of 18 to 39 years old. The total expected participant count is 160 people."

Answered by AI

Are those over 40 years of age eligible to participate in this investigation?

"As articulated in the trial's prerequisites, only patients between 18 and 39 years old can be enrolled."

Answered by AI

How many participants are being included in this medical experiment?

"Affirmative. As evidenced on clinicaltrials.gov, this research is actively searching for participants to enrol; it was first published February 8th 2021 and last modified April 12th 2022. The trial requires 160 individuals at one single location."

Answered by AI
~28 spots leftby Dec 2024